Back to results
US 2012/0258957 A1Published application
Heterocyclic derivatives
OwnerMatilda Jane Bingham, Andrew Dunbar +2inventors
InventorsMatilda Jane Bingham, Andrew Dunbar, Margaret Jean Laats, Grant Wishart
Life of this patent
Estimating the term…
Abstract
The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders or diseases influenced by modulation of orexins, such as sleep disorders.
Claims15
1-15. (canceled)
A heterocyclic derivative having the formula I
- wherein
- X1 and X2 are independently CH or N with the proviso that one of X1 and X2 is N;
- Y1-Y4 are CR1 or 1-2 of Y1 to Y4 are N;
- Z1-Z4 are CR2 or 1-2 of Z1 to Z4 are N;
- Each R1 and R2 is independently H, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C2-6alkenyloxy, C3-7cycloalkyl, C3-7cycloalkyloxy, OH, halogen or CN said C1-6alkyl and C1-6alkoxy being optionally substituted with one or more halogens;
- Each R3 is independently H, C1-6alkyl or C3-7cycloalkyl said C1-6alkyl and C3-7cycloalkyl being optionally substituted with one or more substituent independently selected from halogen, OH, CN, NR4R5 and C1-6alkoxy;
- R4 and R5 are independently H or C1-6alkyl or R4 and R5 together with the N to which they are bonded form a 4-7 membered heterocyclic ring;
- Ar is C6-10aryl or a 5-10 membered heteroaryl ring system comprising 1-3 heteroatoms independently selected from N, O and S, said C6-10aryl or 5-10 membered heteroaryl being optionally substituted with 1-3 R6;
- Each R6 is independently selected from C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C2-6alkenyloxy, C3-7cycloalkyl, C3-7cycloalkyloxy, OH, halogen, CN and a 5-6 membered heteroaryl comprising 1-2 heteroatoms selected from N, O and S, said C1-6alkyl and C1-6alkoxy being optionally substituted with one or more halogens;
- m is 0 or 1 and
- n is 1 or 2
- or a pharmaceutically acceptable salt thereof.
9 more elements
Dependencies are inferred from the claim text.